Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Osteogenesis imperfecta describes a group of genetic disorders that result from a defect in collagen type I and range in severity from a subtle increase in fracture frequency to death in the perinatal period. Osteogenesis imperfecta is mostly caused by mutations in the COL1A1 (17q21.33) and COL1A2 (7q21.3) genes. There have only been a few case reports of implant-prosthetic treatment for patients with osteogenesis imperfecta. These reports indicated that implants and augmentation procedures can be implemented in such patients. However, for patients receiving additional antiresorptive therapy, cautious approaches should be chosen and the risk of drug-associated osteonecrosis should be considered. The aim of this article is to report on the implant-prosthetic treatment of a patient with type I osteogenesis imperfecta.

Citation

Marcel Hanisch, Melanie Maus, Johannes Kleinheinz. Implant-Prosthetic Restoration of a Patient with Osteogenesis Imperfecta: A Case Report. International journal of environmental research and public health. 2021 Apr 15;18(8)

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 33920808

View Full Text